CIC, a global leader in building and operating innovation communities, and Persephoni BioPartners, a strategic advisory and Biotech venture studio firm, are excited to announce a strategic partnership built around CIC Philadelphia’s location in uCity Square to drive growth and development of early-stage biotech companies in Philadelphia.

“We are incredibly excited to call CIC our home for our Philadelphia operations. Their state of the art facilities will enable our current portfolio companies to accelerate their research and development as we prepare for clinical advancement. We aim to serve across the ecosystem and facilitate cross organizational and institutional collaborations to serve the amazing technologies housed within Philadelphia,” said Hilary Schultz, CEO of Persephoni BioPartners

Persephoni has an office on the 7th floor of CIC Philadelphia at 3675 Market Street in the uCity Square Knowledge Community, where it will serve as a landing pad for the companies in its venture studio program. It will also open its doors to existing CIC members, offering advisory services ranging from startup incorporation and capitalization table structure, strategic planning, regulatory strategy, capital raise, and business development to support strategic partnerships.

Read more